Hospira Earnings Preview: Can This Streak Continue?

Hospira (NYSE:HSP) will report earnings before markets open on Wednesday, May 1st. Hospira, Inc. is a global specialty pharmaceutical and medication delivery company. The Company’s product portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems.

Here is your Cheat Sheet to Hospira Earnings:

Earnings Expectations: Analysts expect earnings of $0.44 per share on revenues of $979.33 million. Currently, the company’s P/E ratio stands at 118.36.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.6 to a profit $0.51. For the current year, the average estimate is a profit of $2.03, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Hospira has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 3,630 3,879 3,917 4,057 4,092
Diluted EPS ($) 1.99 2.47 2.11 -0.06 0.27

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 1,014 965.90 1,033 994.00 1,099
Diluted EPS ($) -1.300 0.24 -0.02 0.01 0.0319

Past Performance:
Hospira has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)